ProAssurance Corporation (NYSE: PRA) shareholders have delivered a decisive mandate for the company's acquisition by The Doctors Company, with over 99% of voting shares endorsing the $1.3 billion...
The $3.3 billion standoff between Surgery Partners and Bain Capital represents a defining moment in healthcare private equity, revealing fundamental tensions between short-term liquidity events and...
Eli Lilly's acquisition of Verve Therapeutics for up to $1.3 billion marks a watershed moment in the convergence of gene editing and cardiovascular therapeutics. This deal, announced on June 17,...
The Pennsylvania House of Representatives has passed landmark legislation (House Bill 1460) imposing unprecedented oversight on private-equity healthcare transactions, marking a watershed moment in...
In a landmark consolidation of Germany's biotechnology sector, BioNTech SE (NASDAQ: BNTX) has announced its acquisition of CureVac NV (NASDAQ: CVAC) through an all-stock transaction valued at $1.25...
Private equity giant Advent International has positioned itself at the forefront of the emerging animal health generics market through a $175 million strategic investment in Ireland-based Felix...
Edinburgh-based healthcare SaaS provider Craneware has rebuffed a £26.50-per-share acquisition proposal from Bain Capital, asserting the $1.3 billion valuation fundamentally misprices its market...
UnitedHealth Group's potential $1 billion divestiture of its Banmedica subsidiary marks a pivotal moment in corporate strategy realignment, reflecting both sector-specific challenges and broader...
The mutual termination of Owens & Minor's proposed $1.36 billion acquisition of Rotech Healthcare marks a pivotal moment in the home medical equipment sector, exposing regulatory landmines in...
French beauty conglomerate L'Oréal stands poised to finalize one of 2025's most significant beauty acquisitions with its €1 billion purchase of UK clinical skincare pioneer Medik8 . This...
